Iranian Journal of Pathology

Prevalence of Cervical Pap Smear Epithelial Abnormalities in Iraqi Women and Its Correlation with Histopathology

Document Type : Original Research

Authors

Mais Mohammed Salim Mohammed Hasan 1
Iftikhar Kudair Abbas 1
Ibtihal Chiad Abbas 1
Kaswer Musa Jaafar 1
Rana Talib Fakher 2

1 Department of Pathology and Forensic Medicine, Faculty of Medicine, University of Kufa, Najaf Governorate, Iraq

2 Department of Medical Microbiology, Faculty of Medicine, University of Kufa, Najaf Governorate, Iraq

https://doi.org/10.30699/ijp.2025.2064544.3490
Abstract
Background & Objective: Cervical carcinoma is the fourth most common malignancy among women worldwide, with a disproportionately high incidence and mortality in developing countries, including Iraq, where 320 new cases and 62 deaths were reported in 2023. Although the Papanicolaou (Pap) smear remains the cornerstone of screening, findings across Arab populations have been inconsistent, underscoring the need for region-specific data. This study aimed to determine the prevalence and patterns of cervical epithelial cell abnormalities and assess the diagnostic accuracy of Pap smears in Najaf, Iraq.
Methods: This retrospective, cross-sectional study was conducted over ten years (December 2014–December 2024) and included 3522 cervical Pap smears from women aged 16 to 80 years (mean, 36.97 ± 10.62 years) obtained at a private medical laboratory. Samples were classified according to the 2014 Bethesda System.
Results: Of 3522 samples, epithelial cell abnormalities were identified in 192 (5.45%). Atypical squamous cells of undetermined significance (ASC-US) were the most frequent abnormality (3.78%). The highest prevalence was observed among women aged 40 to 60 years. A strong cytohistopathologic correlation was noted. The Pap test demonstrated a sensitivity of 76.19%, specificity of 80.30%, and overall diagnostic accuracy of 79.31%.
Conclusion: The 5.45% prevalence of epithelial abnormalities, predominantly ASC-US, highlights the ongoing need for active cervical cancer screening programs. The significant concordance between cytologic and histopathologic findings confirms the diagnostic reliability of the Pap smear. Further studies are warranted to characterize local cytologic patterns and identify prevalent HPV genotypes to inform HPV vaccination and targeted prevention strategies.

Keywords

Cervical Cancer Screening
Pap Smear
Diagnostic Accuracy

Subjects

Copyright © 2026. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license also allows users to adapt, remix, transform, and build upon the material for any purpose, including commercial use.

1.        Chen S, Cao Z, Prettner K, Kuhn M, Yang J, Jiao L, et al. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 2023;9(4):465‐472. [DOI:10.1001/jamaoncol.2022.7826] [PMID] [PMCID]
2.        Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-86. [DOI:10.1002/ijc.29210] [PMID]
3.        Iraqi cancer registry 2023.
4.        Jhingran A, Russel AH, Seiden MV, Duska LR, Goodman A, Lee SL, et al. Cancers of the cervix, vulva, and vagina. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE. Abeloff's Clinical Oncology, 6th ed. Netherlands:Elsevier, 2019. p.1468507. [DOI:10.1016/B978-0-323-47674-4.00084-0]
5.        Ngelangel C, Muñoz N, Bosch FX, Limson GM, Festin MR, Deacon J, et al. Causes of cervical cancer in the Philippines: A case-control study. J Natl Cancer Inst 1998; 90:43-9. [DOI:10.1093/jnci/90.1.43] [PMID]
6.        Green J, Berrington de Gonzalez A, Sweetland S, Beral V,Chilvers C, Crossley B, et al. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National case-control study of cervical cancer. Br J Cancer 2003; 89:2078-86. [DOI:10.1038/sj.bjc.6601296] [PMID] [PMCID]
7.        Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55:244-65. [DOI:10.1136/jcp.55.4.244] [PMID] [PMCID]
8.        Koss LG, Stewart F, Foote FW, Jordan MJ, Bader GM, Day E. Some histological aspects of behavior of epidermoid carcinoma in situ and related lesions of the uterine cervix. A long-term prospective study. Cancer 1963; 16:1160-211. https://doi.org/10.1002/1097-0142(196309)16:9<1160::AID-CNCR2820160910>3.0.CO;2-4 [DOI:10.1002/1097-0142(196309)16:93.0.CO;2-4] [PMID]
9.        Ugboma HAA, Aburoma HLS. Pap smear: An important screening technique for preventing and detecting cervical cancer. Continental J Med Res 2010; 4:13-17.
10.     Bodal VK, Brar RK, Bal MS, Kaur B, Kaur S, Suri AK, et al. Correlation of Pap smear with histopathological findings in malignant and nonmalignant lesions of cervix. Global Journal of Medical Research. 2014;14:19-24. http://creativecommons.org/licenses/by-nc/3.0/
11.     Patel M, Pandya A, Modi J. Cervical Pap smear study and its utility in cancer screening to specify the strategy for cervical cancer control. National Journal of Community Medicine. 2011;2:49-51. https://njcmindia.com/index.php/file/article/view/1842
12.     United Nations Population Fund. Comprehensive cervical cancer prevention and control: Programme guidance for countries. From: https://www.unfpa.org/resources/comprehensivecervical-cancer-prevention-and-control-programmeguidance-countries Accessed: Sept 2020.
13.     Nasar A, Waad A, Atheer A, Nasra A. Awareness of cervical cancer and Pap smear testing among Omani women. Asian Pac J Cancer Prev 2016; 17:4825-30. [DOI:10.22034/APJCP.2016.17.11.4825] [PMID] [PMCID]
14.     Ghazal-Aswad S, Gargash H, Badrinath P, Al-Sharhan MA, Sidky I, Osman N, et al. Cervical smear abnormalities in the United Arab Emirates: A pilot study in the Arabian Gulf. Acta Cytol 2006; 50:41-7. [DOI:10.1159/000325893] [PMID]
15.     Kapila K, Sharma PN, George SS, Al-Shaheen A, Al-Juwaiser A, Al-Awadhi R. Trends in Epithelial Cell Abnormalities Observed on Cervical Smears over a 21-Year Period in a Tertiary Care Hospital in Kuwait. Sultan Qaboos Univ Med J. 2015 Feb;15(1):e112-5. Epub 2015 Jan 21. [DOI:10.18295/2075-0528.1662]
16.     Balaha MH, Al Moghannum MS, Al Ghowinem N, Al Omran S. Cytological pattern of cervical Papanicolaou smear in eastern region of Saudi Arabia. J Cytol 2011; 28:173-7. [DOI:10.4103/0970-9371.86343] [PMID] [PMCID]
17.     Maraqa B, Lataifeh I, Otay L, Badran O, Nouri YQ, Issam I, et al. Prevalence of abnormal Pap smears: A descriptive study from a cancer center in a low-prevalence community. Asian Pac J Cancer Prev 2017; 18:3117-21. [DOI:10.22034/APJCP.2017.18.11.3117] [PMID] [PMCID]
18.     Al Sekri E, Al Musalhi A, Al Abri K, Al Kindi H, Al Salmani AA. Prevalence of Cytological Abnormalities in Papanicolaou Smears and Risk Factors for Cervical Cancer Among Women in Muscat, Oman. Sultan Qaboos Univ Med J. 2021 Nov;21(4):598-603. [DOI:10.18295/squmj.4.2021.041] [PMID] [PMCID]
19.     Maleki A, Ahmadnia E, Avazeh A, Mazloomzadeh S, Molaei B, Jalilvand A. Prevalence of abnormal Papanicolaou test results and related factors among women living in Zanjan, Iran. Asian Pac J Cancer Prev 2015; 16:6935-9.            [DOI:10.7314/APJCP.2015.16.16.6935] [PMID]
20.     Balaha MH, Al Moghannum MS, Al Ghowinem N, Al Omran S. Cytological pattern of cervical Papanicolaou smear in eastern region of Saudi Arabia. J Cytol 2011; 28:173-7. [DOI:10.4103/0970-9371.86343] [PMID] [PMCID]
21.     Atilgan R, Celik A, Boztosun A, Ilter E, Yalta T, Ozercan R. Evaluation of cervical cytological abnormalities in Turkish population. Indian J Pathol Microbiol 2012; 55:52-5. [DOI:10.4103/0377-4929.94856] [PMID]
22.     World Health Organization. The Global Health Observatory: Cervical cancer screening. Geneva: World Health Organization. From:    https://www.who.int/health-topics/cervicalcancer Accessed: Sept 2020.
23.     Banik U, Bhattacharjee P, Ahamad SU, Rahman Z. Pattern of epithelial cell abnormality in Pap smear: A clinicopathological and demographic correlation. Cyto journal 2011; 8:8. [DOI:10.4103/1742-6413.80527] [PMID] [PMCID]
24.     Shipitsyna E, Zolotoverkhaya E, Kuevda D, Nasonova V, Romanyuk T, Khachaturyan A, et al. Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia. Cancer epidemiology. 2011;35(2):160-4. [DOI:10.1016/j.canep.2010.08.010] [PMID]
25.     .El All HSA, Refaat A, Dandash K. Prevalence of cervical neoplastic lesions and human papilloma virus infection in Egypt: national cervical cancer screening project. Infectious agents and cancer. 2007;2(1):12. [DOI:10.1186/1750-9378-2-12] [PMID] [PMCID]
26.     Stolnicu S, Musca S, Micu D, Micu L, Moldovan C, Puscasiu L. Prevalence of abnormal Pap smears in a consecutive and previously unscreened population in Romania. International Journal of Gynecology & Obstetrics. 2014;124(2):156-9. [DOI:10.1016/j.ijgo.2013.07.030] [PMID]
27.     Jena A, Bharathi T, Reddy S, Manilal B, Patnayak R, Phaneendra B. Papanicolaou (Pap) test screening of staff members of a tertiary care teaching hospital in South India. J Clin Sci Res. 2012;1:174-7 [DOI:10.4103/2277-5706.241514]
28.     28.Massomi Z, Khani S, Gharosian M, Farhadian M, Shayan A. The Prevalence of Abnormal Pap Smears in females Referred to Health Centers Affiliated to Medical Sciences During the Years 2012 to 2016. J Educ Community Health. 2016;3(2):16-22. [DOI:10.21859/jech-03023]
29.     Hassooni, ZA; Al-Sabbagh, WM; Taher, TJ. Evaluation of cervical cytological abnormalities in correlation with clinical findings in Iraqi patients. Medical Journal of Babylon 2024;21(1):p 144-148.        [DOI:10.4103/MJBL.MJBL_503_23]
30.     Elhakeem HA, Al-Ghamdi AS, Al-Maghrabi JA. Cytopathological pattern of cervical Pap smear according to the Bethesda system in Southwestern Saudi Arabia. Saudi Med J. 2005 Apr;26(4):588-92. [PMID]
31.     Farzaneh F, Jamdar F, Younesi S, Taheri M, Saadati P, Navidpour F, et al. The Trend of Abnormal Cervical Cytology Among Iranian Women During Recent Years from 2013 to 2016. Journal of Obstetrics, Gynecology and Cancer Research, 2022; 4(1), pp. 29 35.
32.     Tailor H J, R.D., Patel, P. R., & Bhagat, V M. Study of cervical pap smears in a tertiary care hospital of south Gujarat, India. International Journal of Research in Medical Sciences,2016; 4(1), 286-288. [DOI:10.18203/2320-6012.ijrms20160044]
33.     Aledan NA kareem, Hussien WAL. The Cervical pap smear cytological changes with clinicopathological correlation in a sample of Iraqi patients. Iraq Med J.2021;5(3):75-80. [DOI:10.22317/imj.v5i3.1018]
34.     Naik R, Minj MM, Panda R, Satpathi S, Behera PK, Panda KM. Cytohistological correlation and accuracy of the pap smear test in diagnosis of cervical lesions: a hospital based cross-sectional study from Odisha, India. Medical Science. 2015;3:242-9 [DOI:10.29387/ms.2015.3.3.242-249]
35.     Saha R, Thapa M. Correlation of cervical cytology with cervical histology. Kathmandu Univ Med J (KUMJ). 2005;3:222-4. [PMID]
36.     Jain V, Vyas AS. Neoplasia cyto-histological correlation (Bethesda system) a study of 276 cases. J cytol Histol. 2010;1:106. [DOI:10.4172/2157-7099.1000106]
37.     Chaudhary RD, Inamdar SA, Hariharan C. Correlation of diagnostic efficacy of unhealthy cervix by cytology, colposcopy and histopathology in women of rural areas. Int J Reprod Contracept Obstet Gynecol. 2014;3:213-218. [DOI:10.5455/2320-1770.ijrcog20140343]
38.     Ashmita D, Shakuntala PN, Rao SR, Sharma SK, Geethanjali S. Comparison and correlation of pap smear, coploscopy and histopathology in symptomatic women and suspicious looking cervix in a tertiary hospital care centre. Int J Health Sci Res. 2013;3:50-9.
39.     Mallur PR, Desai BR, Anita D, Geeta D, Bhavana S, Pallav G. Sequential screening with cytology and colposcopy in detection of cervical neoplasia. J South Asian Feder Obst Gynae. 2009;1:45-48.          [DOI:10.5005/jp-journals-10006-1009]
40.     Zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2002; 2:342-50. [DOI:10.1038/nrc798] [PMID]
41.     Banik U, Bhattacharjee P, Ahamad SU, Rahman Z. Pattern of epithelial cell abnormality in Pap smear: A clinicopathological and demographic correlation. Cytojournal 2011; 8:8. [DOI:10.4103/1742-6413.80527] [PMID]
42.     Ranabhat SK, Shrestha R, Tiwari M. Analysis of abnormal epithelial lesions in cervical pap smears in mid-Western Nepal. Journal Pathology of Nepal. 2011;1:30-3. [DOI:10.3126/jpn.v1i1.4447]
43.     World Health Organization. The Global Health Observatory: Cervical cancer screening. Geneva: World Health Organization. From: https://www.who.int/health-topics/cervicalcancer#tab=tab_1  Accessed: Sept 2020
Iranian Journal of Pathology
Volume 21, Issue 1
Winter 2026
Pages 98-105

  • Receive Date 19 July 2025
  • Revise Date 26 August 2025
  • Accept Date 14 October 2025

Home

Guide for Authors

Submit Manuscript

Contact Us